Vimarsana
Biggest News Aggregation in the World

Quench Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quench Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quench Bio Today - Breaking & Trending Today

Valence Discovery Grows Leadership Team with Key Drug Discovery Hires - Vimarsana News

Valence Discovery Grows Leadership Team with Key Drug Discovery Hires

Following successful partnerships with leading biotech and pharmaceutical companies, Valence adds industry veterans to its leadership team to support development of its in-house drug discovery pipelineMONTREAL & CAMBRIDGE, Mass.--(BUSINESS WIRE)--#AI--Valence Discovery (“Valence”), a leader in AI-driven drug discove...

Samantha Truex on biotech hiring, competing for funding and Upstream's next steps - Vimarsana News

Samantha Truex on biotech hiring, competing for funding and Upstream's next steps

BioPharma

Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer - Vimarsana News

Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer

Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer April 15, 2021 02:00 ET | Source: Sitryx Therapeutics Sitryx Therapeutics LONDON, UNITED KINGDOM Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer Oxford, UK – 15 April 2021 – Sitryx (“the Company”), a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation, today announces ...

Quench Bio Winds Down Operations Following 'Successful Failure' - Vimarsana News

Quench Bio Winds Down Operations Following 'Successful Failure'

The company announced its decision Tuesday in a series of posts on Twitter. In what Quench Bio called a “successful failure,” the company said its drug target proved undruggable to its efforts. Quench was developing an approach to inhibit Gasdermin D, which was believed to be a key target at the core of multiple inflammatory cell death pathways, including pyroptosis and NETosis. When pyroptosis or NETosis pathways are activated, gasdermin is processed and forms lytic pores on the cell membrane, allowing release of inflammatory cytokines, alarmins, DNA and NETs. Pyroptosis and NETosis are...

Annual Results for the Twelve Months ended 31 December 2020 - Vimarsana News

Annual Results for the Twelve Months ended 31 December 2020

Arix Bioscience PLC: Annual Results for the Twelve Months ended 31 December 2020 DJ Annual Results for the Twelve Months ended 31 December 2020 Arix Bioscience PLC (ARIX) Annual Results for the Twelve Months ended 31 December 2020 09-March-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- Arix Bioscience plc Annual Results for the Twelve Months ended 31 Dece...